507 results on '"Rantapää-Dahlqvist S"'
Search Results
2. POS1047 STATIN USE ATTENUATES THE IMPACT OF SYSTEMIC INFLAMMATION ON ISCHEMIC CARDIOVASCULAR RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS
3. AB0172 ANTI-MITOFUSIN-1 AND THROMBOSPONDIN-1 AS POTENTIAL MARKERS FOR POLYMYALGIA RHEUMATICA
4. OP0101 B CELL POLYGENIC RISK SCORES ASSOCIATED WITH ANTI-DSDNA ANTIBODIES AND NEPHRITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS
5. POS0030 METHOTREXATE USE ASSOCIATES WITH ISCHEMIC CARDIOVASCULAR RISK REDUCTION IN MALES BUT NOT FEMALES WITH RHEUMATOID ARTHRITIS
6. POS0214 IN-DEPTH ANALYSIS OF DISEASE MANIFESTATIONS IN ANCA-ASSOCIATED VASCULITIDES IDENTIFIES DISTINCT CLINICAL PHENOTYPES, EMPHASIZING THE IMPACT OF SEX AND AGE AT DIAGNOSIS
7. POS1438 ANALYSIS OF THE PLASMA PROTEOME PROVIDES MECHANISTIC INSIGHTS INTO THE PATHOPHYSIOLOGY OF ANCA-ASSOCIATED VASCULITIS
8. POS1468 A HIGH GENETIC RISK OF SLE IS ASSOCIATED WITH AN INCREASED RISK OF MYOCARDIAL INFARCTION AND IMPAIRED KIDNEY FUNCTION; A COMBINED OBSERVATIONAL AND MENDELIAN RANDOMIZATION STUDY
9. OP0024 DOES ANTIRHEUMATIC MEDICAL TREATMENT OF RHEUMATOID ARTHRITIS AFFECT SURVIVAL AFTER FIRST ACUTE MYOCARDIAL INFARCTION
10. POS0034 BIOLOGIC USE REGULATES THE IMPACT OF INFLAMMATION ON ISCHEMIC CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS
11. S10.2 Interaction between HLA-DRB1*03:01 and stat4 is associated with increased risk of nephritis in systemic lupus erythematosus
12. PO.4.94 High B-cell polygenic risk is associated with dsDNA antibodies and nephritis in systemic lupus erythematosus
13. Diet and alcohol as risk factors for rheumatoid arthritis: a nested case–control study
14. OP0307 PULMONARY FIBROSIS IN EARLY RHEUMATOID ARTHRITIS IN RELATION TO GENETIC LOCI AND INDIVIDUAL ACPA SPECIFICITIES
15. POS0245 PROTEIN PROFILING IN PRE-SYMPTOMATIC ANCA-ASSOCIATED VASCULITIS INDIVIDUALS.
16. POS0603 CARDIOVASCULAR RISK FACTORS BEFORE ONSET OF RHEUMATOID ARTHRITIS ARE ASSOCIATED WITH CARDIOVASCULAR EVENTS AFTER DISEASE ONSET – A CASE CONTROL STUDY
17. Complement activation prior to symptom onset in myeloperoxidase ANCA-associated vasculitis but not proteinase 3 ANCA associated vasculitis - A Swedish biobank study
18. 541 - Mitochondrial-mediated platelet activation in patients with polymyalgia rheumatica
19. ACPA-IgG variable domain glycosylation increases before the onset of rheumatoid arthritis and stabilizes thereafter; a cross-sectional study encompassing over 1500 samples
20. Association of Valine and Leucine at HLA–DRB1 Position 11 With Radiographic Progression in Rheumatoid Arthritis, Independent of the Shared Epitope Alleles but Not Independent of Anti–Citrullinated Protein Antibodies
21. Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab
22. Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: An international audit
23. Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit
24. Observations favouring the occurrence of local production and marked effects of bombesin/gastrin-releasing peptide in the synovial tissue of the human knee joint – Comparisons with substance P and the NK-1 receptor
25. Does a Genetic Variant in FOXO3A Predict a Milder Course of Rheumatoid Arthritis?
26. Smoking cessation is associated with lower disease activity and predicts cardiovascular risk reduction in rheumatoid arthritis patients
27. The R620W C/T polymorphism of the gene PTPN22 is associated with SLE independently of the association of PDCD1
28. Association between inflammasome-related polymorphisms and psoriatic arthritis
29. Contribution of IKBKE and IFIH1 gene variants to SLE susceptibility
30. Disease Manifestations and HLA Antigens in Psoriatic Arthritis in Northern Sweden
31. Cytokine mRNA Profile of Alveolar T Lymphocytes and Macrophages in Patients with Systemic Sclerosis Suggests a Local Tr1 Response
32. Anti-cyclic citrullinated peptide antibodies are associated with radiographic damage but not disease activity in early rheumatoid arthritis diagnosed in 2006–2011
33. Extent of atherosclerosis after 11-year prospective follow-up in patients with early rheumatoid arthritis was affected by disease severity at diagnosis
34. SAT0590 ORAL MICROBIOTA IDENTIFIES PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
35. THU0296 PROTEIN PROFILING IN INDIVIDUALS BEFORE ONSET OF ANCA-ASSOCIATED VASCULITIS
36. SAT0253 ANTI-NEUTROPHIL CYTOPLASMATIC ANTIBODIES PREDATE SYMPTOM ONSET OF ANCA-ASSOCIATED VASCULITIS. A CASE-CONTROL STUDY
37. Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006
38. Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register
39. Availability of iron and degree of inflammation modifies the response to recombinant human erythropoietin when treating anemia of chronic disease in patients with rheumatoid arthritis
40. Echocardiographic findings, lipids and lipoprotein(a) in patients with systemic lupus erythematosus
41. Genetic variations in the serotonin 5-HT2A receptor gene (HTR2A) are associated with rheumatoid arthritis
42. Chromosomal changes in rheumatoid arthritis patients treated with CPH82
43. Targeted next-generation sequencing suggests novel risk loci in juvenile onset systemic lupus erythematosus
44. HLA antigens in polymyalgia rheumatica in Northern Sweden
45. Are Neuropeptides Important in Arthritis?: Studies on the Importance of Bombesin/GRP and Substance P in a Murine Arthritis Model
46. Up regulation of monocyte chemoattractant protein-1 expression in anti-citrulline antibody and immunoglobulin M rheumatoid factor positive subjects precedes onset of inflammatory response and development of overt rheumatoid arthritis
47. Decreased density of serotonin 5-HT2A receptors in rheumatoid arthritis
48. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset
49. Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation
50. Tissue plasminogen activator, plasminogen activator inhibitor-1 and von willebrand factor in rheumatoid arthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.